Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II

被引:0
|
作者
Poitras, M [1 ]
Sidibe, A [1 ]
Richard, DE [1 ]
Chretien, L [1 ]
Guillemette, G [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada
来源
RECEPTORS & CHANNELS | 1998年 / 6卷 / 01期
关键词
Angiotensin II; AT(1) receptor; antagonist; GTP gamma S; pentosan sulfate; uncoupling agents;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AT(1) receptor is responsible for most of the physiological effects of Angiotensin II (Ang II). AT(1) receptor belongs to the G-protein-coupled receptor (GPCR) family, and it mediates its actions through the coupling of the G(q/11) protein with phospholipase C beta. Classical pharmacology has used the sensitivity of GPCR ligands to uncoupling agents as a criteria to discriminate agonists (which are sensitive) from antagonists (which are insensitive). In this study, the uncoupling agents GTP gamma S and pentosan sulfate (PS) (a low molecular weight polyanion) were used to further characterize the molecular interactions between Ang II analogs and the AT(1) receptor. We show that some Ang II antagonists are sensitive to the conformational change of the AT(1) receptor induced by uncoupling agents. These results demonstrate that there is no direct relationship between the intrinsic activity of a ligand and its affinity for different conformations of the AT(1) receptor and that the sensitivity of GPCR ligands to uncoupling agents can not be used as a criteria to discriminate agonists from antagonists.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [21] Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II
    Laporte, SA
    Boucard, AA
    Servant, G
    Guillemette, G
    Leduc, R
    Escher, E
    MOLECULAR ENDOCRINOLOGY, 1999, 13 (04) : 578 - 586
  • [22] 3-D-QSAR studies of diphenylpropionic acids based selective AT1 angiotensin II receptor antagonist as antihypertensive agents
    Solomon, VR
    Chaturvedi, SC
    INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2004, 13 (04) : 373 - 378
  • [23] Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist
    Moulder, JE
    Fish, BL
    Cohen, EP
    RADIOTHERAPY AND ONCOLOGY, 1998, 46 (03) : 307 - 315
  • [24] Radioligands for the Angiotensin II Subtype 1 (AT1) Receptor
    Mathews, William B.
    Szabo, Zsolt
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (16) : 1585 - 1599
  • [25] The effect of angiotensin II on intracellular pH is mediated by AT1 receptor translocation
    Thieme, Karina
    Eguti, Debora Mai N.
    Mello-Aires, Margarida
    Oliveira-Souza, Maria
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2008, 295 (01): : C138 - C145
  • [26] Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor:: possible role of AT1 receptor dimerization
    Yamada, Masahiro
    Kushibiki, Motoi
    Osanai, Tomohiro
    Tomita, Hirofumi
    Okumura, Ken
    CARDIOVASCULAR RESEARCH, 2008, 79 (01) : 169 - 178
  • [27] Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection:: The case for AT1 receptor antagonist
    Berl, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : S71 - S76
  • [28] The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression
    Y. Nishimura
    T. Xu
    O. Jöhren
    W. Häuser
    J.M. Saavedra
    Basic Research in Cardiology, 1998, 93 (Suppl 2) : s063 - s068
  • [29] The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression
    Nishimura, Y
    Xu, T
    Jöhren, O
    Häuser, W
    Saavedra, JM
    BASIC RESEARCH IN CARDIOLOGY, 1998, 93 : 63 - 68
  • [30] Differential effect of ACE inhibitor and angiotensin II (Ang II) type 1 receptor (AT1) antagonist on the responsiveness to Ang II in ventrolateral medulla of SHR
    Tsuchihashi, T
    Kagiyama, S
    Abe, I
    Fujishima, M
    HYPERTENSION, 1998, 32 (03) : 613 - 613